Intellipharmaceutics International Analysis

Intellipharmaceutics OTC Stock Analysis Notes

The company recorded a loss per share of 0.16. Intellipharmaceutics last dividend was issued on the 14th of September 2018. The entity had 1:10 split on the 14th of September 2018. Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. The company was founded in 1998 and is based in Toronto, Canada. Intellipharmaceutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 11 people.The quote for Intellipharmaceutics International is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Intellipharmaceutics International call the company at 416 798 3001 or check out https://www.intellipharmaceutics.com.

Intellipharmaceutics Investment Alerts

Intellipharmaceutics Upcoming and Recent Events

Intellipharmaceutics Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Intellipharmaceutics's market, we take the total number of its shares issued and multiply it by Intellipharmaceutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Intellipharmaceutics Outstanding Bonds

Intellipharmaceutics Predictive Daily Indicators

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Intellipharmaceutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Intellipharmaceutics shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Intellipharmaceutics. By using and applying Intellipharmaceutics OTC Stock analysis, traders can create a robust methodology for identifying Intellipharmaceutics entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.